Literature DB >> 15115510

Pruritus in adult dermatomyositis.

Z Shirani1, M J Kucenic, C L Carroll, A B Fleischer, S R Feldman, G Yosipovitch, J L Jorizzo.   

Abstract

Dermatomyositis has a significant clinical component of pruritus that has not yet been studied. Pruritus can significantly affect the life of patients. The aim of the present work was to study the degree of pruritus experienced by patients. A four-question survey was sent to patients with documented dermatomyositis. The survey used a 100-mm Visual Analogue Scale (VAS) to describe current, worst and daily pruritus, and the effect this has on daily activities. Twenty-six subjects returned completed questionnaires: four had no pruritus; the majority had a significant amount with means above 50 on the VAS. A mean of 44.6 was found for the effect on daily life. Further studies should be performed to examine the prevalence and severity of pruritus in this population and it's effect on their quality of life. Clinicians must be aware of the significant pruritus and provide adequate therapy to improve quality of life.

Entities:  

Mesh:

Year:  2004        PMID: 15115510     DOI: 10.1111/j.1365-2230.2004.01510.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  19 in total

1.  Quality of life in dermatomyositis.

Authors:  Renato Goreshi; Monika Chock; Kristen Foering; Rui Feng; Joyce Okawa; Matt Rose; David Fiorentino; Victoria Werth
Journal:  J Am Acad Dermatol       Date:  2011-07-01       Impact factor: 11.527

Review 2.  Scalp Itch: A Systematic Review.

Authors:  Norma Elizabeth Vázquez-Herrera; Divya Sharma; Nouf Mohammed Aleid; Antonella Tosti
Journal:  Skin Appendage Disord       Date:  2017-11-29

3.  [Chronic pruritus in autoimmune dermatoses : results of a comparative survey].

Authors:  L Schröder; M Hertl; E Chatzigeorgakidis; N Q Phan; S Ständer
Journal:  Hautarzt       Date:  2012-07       Impact factor: 0.751

Review 4.  Chronic pruritus: a paraneoplastic sign.

Authors:  Gil Yosipovitch
Journal:  Dermatol Ther       Date:  2010 Nov-Dec       Impact factor: 2.851

5.  Inflammatory myopathies: One-center experience.

Authors:  Metin Işık; Şule Bilgen; İsmail Doğan; Levent Kılıç
Journal:  Eur J Rheumatol       Date:  2014-09-01

6.  Itch in dermatomyositis: the role of increased skin interleukin-31.

Authors:  H J Kim; M Zeidi; D Bonciani; S M Pena; J Tiao; S Sahu; V P Werth
Journal:  Br J Dermatol       Date:  2018-06-21       Impact factor: 9.302

7.  Improvement in the cutaneous disease activity of patients with dermatomyositis is associated with a better quality of life.

Authors:  E S Robinson; R Feng; J Okawa; V P Werth
Journal:  Br J Dermatol       Date:  2014-11-30       Impact factor: 9.302

Review 8.  Idiopathic inflammatory myopathies.

Authors:  Mazen M Dimachkie; Richard J Barohn; Anthony A Amato
Journal:  Neurol Clin       Date:  2014-08       Impact factor: 3.806

Review 9.  Idiopathic inflammatory myopathies.

Authors:  Mazen M Dimachkie; Richard J Barohn
Journal:  Semin Neurol       Date:  2012-11-01       Impact factor: 3.420

10.  Dermatomyositis presenting with symptomatic dermographism and raised troponin T: a case report.

Authors:  Kartini F Rahim; Robert S Dawe
Journal:  J Med Case Rep       Date:  2009-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.